Secure Transfusion Services utilizes advanced blood component processing techniques to enhance the safety and availability of transfusable blood products. The company addresses the critical shortage of high-quality blood supplies in healthcare settings, ensuring better patient outcomes and efficient transfusion practices.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare settings face a critical shortage of high-quality blood supplies, which can negatively impact patient outcomes and hinder efficient transfusion practices. Traditional blood component processing techniques may not fully address the need for safer and more readily available transfusable blood products.
Solution
Secure Transfusion Services (STS) employs advanced blood component processing techniques to improve the safety and availability of blood products for transfusion. By optimizing the separation, purification, and storage of blood components, STS aims to reduce the risk of adverse reactions and ensure a more reliable supply of compatible blood for patients in need. The company focuses on enhancing the quality and extending the shelf life of blood products, thereby minimizing waste and maximizing the utility of each donation. STS's approach seeks to address the challenges associated with blood shortages and improve overall transfusion outcomes.
Target Audience
STS primarily serves hospitals, blood banks, and transfusion centers seeking to enhance the safety, quality, and availability of blood products for their patients.
Features
- Advanced blood component separation using novel filtration and centrifugation methods
- Pathogen reduction technologies to minimize the risk of transfusion-transmitted infections
- Leukoreduction techniques to prevent alloimmunization and febrile non-hemolytic transfusion reactions
- Optimized storage solutions to extend the shelf life and maintain the quality of blood products
- Quality control testing to ensure compliance with regulatory standards and safety guidelines